Clinical Trials Browser

Phase 3 × Malignant Carcinoid Syndrome × Endocrine × Clear all

NCT00092287 2020-04-30

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase 3 Terminated

Malignant Carcinoid Syndrome, Serotonin Syndrome

NCT00412061 2014-11-21

RADIANT-2

Phase 3 Completed

429 enrolled 13 charts

Carcinoid Tumor, Carcinoma, Malignant Carcinoid Syndrome, Neoplasms